"Pathways through which HDx could play a role in reducing the rate of severe infections
- reduced inflammation, as supported by lowering of the concentration of inflammatory cytokines and reduced transcription of pro-inflammatory cytokines in peripheral leukocytes
- reduced serum concentration of free light chains (FLC) since their retention in CKD patients is associated with in vitro inhibition of leukocyte chemotaxis"